The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...
Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...
During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...
A new report from the American Cancer Society shows that cancer mortality rates continue to decline, but diagnoses are on the ...
Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback